Japan-based Kaken Pharmaceutical Co. has entered into a license agreement with Johnson & Johnson for the globa...
JCR Pharmaceuticals Co. and Modalis Therapeutics Corporation have validated the initial proof of concept ...
Takeda has announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of HYQVIA [Immun...
Fujirebio Holdings, a wholly-owned subsidiary of H.U. Group Holdings, Inc., and Eisai Co., in Japan, have entered into a...
Japan's Sumitomo Chemical Co. and Sumitomo Pharma have studied restructuring measures to accelerate the development of r...
Takeda Pharmaceutical Company and the Tohoku University Drug Discovery Strategy Promotion Organization have entered into...
Japan-based Shimadzu Corporation has signed an investment contract with U-Medico Inc, a contract research organisation (...
Newron Pharmaceuticals, a biopharmaceutical company focused on the development of novel therapies for patients with dise...
Texas Medical Center (TMC), in the US, in partnership with Japan-based organisations Mitsui Fudosan Co. and&nb...
Israel-based Teva Pharmaceutical Industries has entered into an agreement with JKI, established by the fund managed and ...
SOHM, Inc., a globally recognised pharmaceutical company focused on developing, manufacturing and distributing Generic, ...
Eisai Co., Ltd. and Biogen Japan Ltd. have announced that Eisai has entered into a research collaboration agreement with...
The Indian Institute of Technology (IIT) Roorkee and Kyoto University have announce the inauguration of a joint research...
US-based Kura Oncology, Inc. and Japanese pharmaceutical firm Kyowa Kirin have entered into a global strategic collabora...
Singleron Biotechnologies, a leader in single cell analysis solutions, has announced a new distributor partnership with ...
Numab Therapeutics AG, a clinical stage biotechnology company advancing a proprietary pipeline of multi-specific antibod...
Japan-based Meiji Seika Pharma Co. has announced its investment in ARCALIS, Inc. which is a joint venture between Axcele...
Japan-based Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 578 mi...
US-based Inocras Inc. and Summit Pharmaceuticals International Corporation have signed a Memorandum of understanding (Mo...
Eisai Co. and Eisai’s corporate venture capital subsidiary, Eisai Innovation, Inc. have announced that Eisai Innov...
Japan-headquartered Shimadzu Corporation has announced its investment in US-based Sepragen Corporation, a leading compan...
Japan-based GMP cell CDMO I Peace, Inc., specialising in induced pluripotent stem cells (iPSCs) and iPSC-derived cell th...
Unmatched Industry Participation and Engagement The event featured six concurrent shows—Hospital Expo, Clinics Ex...
Japan's Shimadzu Corporation has released CellTune software for supporting optimisation of cell culture conditions that ...
Japan-based pharmaceutical firm Takeda and Boston Medical Center (BMC) in the US have announced a new collaboration focu...
Namsa, a US-based medical device contract research organisation (CRO) providing comprehensive market access services, an...
Honkuwa Pharmaceutical Co. has reached a strategic alliance agreement with Professor Yoshiki Sawa, a member of the Japan...
Japan-based Ono Pharmaceutical Co. has entered into a license agreement with LigaChem Biosciences, Inc., in South Korea,...
Alpha Fusion, Inc., working on research outcomes from Osaka University and the Japan Science and Technolo...
UK-based AviadoBio and Japan's Astellas Pharma Inc. have announced an exclusive option and license agreement for AVB-101...
Flatiron Health and Lifebit Biotech are expanding their collaboration into Japan to transform cancer care, facilitating ...
Japan-based startup Rege Nephro Co. has successfully developed a funding plan of total 25 billion yen (¥) in new Ser...
Paris-based Curium, a world leader in nuclear medicine, has entered into a strategic partnership with PDRadiopharma Inc,...
Japan's TERUMO Asia Holdings has launched its “Terumo Asia Skill Lab” at its Asia-Pa...
Olympus Corporation, a global medtech company headquartered in Japan, has announced the launch of VISERA S, the all-in-o...
US-based Boston Scientific Corporation has received Pharmaceuticals and Medical Device Agency (PMDA) approval in&nb...
Nxera Pharma, formerly known as Sosei Group or Sosei Heptares, has received approval from the Ministry of Health, Labour...
Japanese pharma firm Takeda has awarded JPY 4.6 billion (approximately $32 million) to five new partners in the field of...
Japan's Shimadzu Corporation has established a subsidiary in Mexico and has begun its activities. To date, in Mexico, an...
US-based iRhythm Technologies, Inc., a leading digital healthcare company focused on creating trusted solutions that det...
Global biotechnology leader CSL and self amplifying-mRNA pioneer Arcturus Therapeutics have announced that Japan's Minis...
Osivax, a FRance-based biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly...
Antibody Engineering & Therapeutics Asia: Date: October 21 – 23, 2024Location: The Westin Miyako Kyoto Antib...
Takara Bio USA, Inc., a wholly owned subsidiary of Japan-based Takara Bio Inc., has announced the launch of the SmartChi...
US-based Rigel Pharmaceuticals, Inc., a commercial stage biotechnology company focused on hematologic disorders and canc...
Rigaku Corporation, a Rigaku Holdings Group company and global partner for X-ray analysis from Lab to Fab in Japan, has ...
The Biomedical Division of PHC Corporation, based in Japan, will present a prototype of its new cell expansion syst...
Japan’s biotech sector is a landscape rife with opportunity, yet also a complex market that requires a deep unders...
Japan has a robust drug discovery capability, having developed an interleukin-6 inhibitor, a programmed cell death prote...
Japan's biotech ecosystem is at a pivotal moment, characterised by both challenges and opportunities. Despite a rich his...
On July 30 2024, Japanese Prime Minister Fumio Kishida unveiled a roadmap to establish Japan as a ‘drug discovery ...
Kaneka Corporation has opened its Tomatoh Manufacturing Site in the Tomakomai Tobu Area of Hokkaido, Japan for the purpo...
Japanese firm Hitachi High-Tech Corporation and Korea-based Gencurix, Inc. have entered a strategic partnership in the f...
Japan-based Olympus Corporation, a global medical technology company, has announced the launch of two new jaw designs in...
Japan-based Hitachi High-Tech Corporation has announced the global launch of TM4000PlusIII and TM4000III Tabletop Micros...
Like in the previous edition, MEDICAL JAPAN TOKYO features six sub shows. First off is the HOSPITAL EXPO, which i...
Aevice Health, a leading provider of remote monitoring solutions for chronic respiratory disease management, has raised ...
Japan-based pharma firm Daiichi Sankyo and global life sciences company Merck, known as MSD outside of the United States...
Japan-based Terumo Corporation has established Terumo Ventures, a Corporate Venture Capital (CVC) organisation responsib...
Japan-based Otsuka Pharmaceutical Co. and Jnana Therapeutics Inc. have entered into a definitive merger agreement ...
Kyowa Kirin Asia Pacific, a wholly owned subsidiary of Japan-based Kyowa Kirin Co., has announced plans to transform its...
Biogen Inc., Beckman Coulter, Inc. (both based in the US) and Japan-based Fujirebio have announced a collaboration to po...
AstraZeneca K.K. and United Immunity have signed an agreement for joint research on next-generation lipid nanoparticles ...
Merck, a leading science and technology company, has signed a non-binding Memorandum of Understanding (MoU) with Gene Th...
Japanese firms Eisai Co. and EcoNaviSta Inc. have entered into a business alliance agreement and commenced collaboration...
Japan-headquartered Fujifilm Corporation has announced the opening of a new NURA health screening centre focusing on...
Japan-headquartered pharma firm Eisai Co. has entered into a license agreement regarding the development and commerciali...
Japan-headquartered Astellas Pharma Inc. and Graduate School of Medicine / Faculty of Medicine, Osaka University ha...
Nipro Medical Corporation, a subsidiary of Japan headquartered Nipro Corporation, has announced its significant expansio...
Acute graft-versus-host disease (aGVHD) is a medical condition that occurs when donor immune cells attack the recipient'...
Shimadzu Corporation has concluded a business partnership agreement with Tescan Group, a leading manufacturer of scannin...
Moderna, Inc. and Mitsubishi Tanabe Pharma Corporation have entered into a joint agreement regarding the co-promot...
TMS Co. has entered into an exclusive worldwide license agreement with Hokkaido University concerning a therapeuti...
The School of Engineering, the University of Tokyo, Shimadzu Corporation and Shionogi & Co. have established the Lab...
Japan-based pharmaceutical firm Eisai Co. has agreed to end its global strategic collaboration with Bristol Myers Squibb...
SoftBank Group Corp. has announced the establishment of a joint venture (JV) SB TEMPUS Corp. with Tempus AI, Inc., a l...
Israel-based firm Medasense, a global leader in pain monitoring solutions, has announced a strategic partnership with Ni...
Japan headquartered Nippon Express Holdings has signed a strategic partnership agreement with Iceland-based Control...
Takeda Pharma has announced that LIVTENCITY (maribavir) has been approved by the Japanese Ministry of Health, ...
Japan-based Healios K.K. has entered into a license agreement with Astellas Institute for Regenerative Medicine (A...
Singapore-based startup Mirxes has announce that its fully-owned subsidiary, Mirxes Japan, has secured a grant of up to ...
Japan-based Shionogi & Co. has entered into an option agreement with French firm Cilcare DEV SAS to acquire the...
Japan-headquartered firm Shimadzu has acquired all shares of Zef Scientific Inc., through its US subsidiary Shimadzu Sci...
Scientists from Nanyang Technological University, Singapore (NTU Singapore) and Chiba University in Japan have shown how...
Asahi Kasei Medical's US subsidiary Bionova Scientific, a full-service biologics CDMO, has decided to launch a new busin...
Fujitsu Japan and Juntendo University have announced the launch of a “Medical Digital Resilience Research Course,&...
Japan-headquartered Shimadzu Corporation has released the LCMS-8060RX, LCMS-8050RX, and LCMS-8045RX triple quadrupole hi...
The consortium of Teijin Limited, Fukui Tateami Co., Ltd., and Osaka Medical and Pharmaceutical University has ann...
A research team at Osaka University, Japan will start an investigator-initiated clinical trial for refractory prostate c...
Asahi Kasei Medical has completed the construction of its third assembly plant for Planova virus removal filters in Nobe...
Japan's Hitachi High-Tech and Swiss firm Roche have extended their partnership, committing to at least 10 years of addit...
Shimadzu Corporation has announced the release of Peakintelligence for LC, software incorporating a proprietary for...
Japan-headquartered Daiichi Sankyo has established two research institutes- DS Research Institute Boston and DS Re...
Eisai Co. and nippon medac Co., a subsidiary of medac group, have launched the anti-rheumatic agent 'Metoject Subcutaneo...
Astellas Pharma Inc. has signed a Memorandum of Understanding (MoU) with Yaskawa Electric Corporation to begin discussio...
Could you elaborate on some of the most prominent trends shaping the landscape of clinical trials in the Asia-Pacific re...
HOYA Group Company, PENTAX of America, Inc. (PENTAX Medical, a division of HOYA Group) and MAGENTIQ-EYE , an artif...
Japan-headquartered pharmaceutical firm Takeda and Swiss firm AC Immune SA have announced an exclusive, worldwide o...
Japan-based Shionogi & Co. and Maze Therapeutics, Inc., in the US, have completed an exclusive worldwide license agr...
The Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 1.64 bill...
